The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (15 analysts) rates it hold, with a mean price target of $246. It reported earnings in this window, a natural checkpoint for the thesis.
Automatic Data Processing ADP
Clears both ethical standardsAn entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Automatic Data Processing, Inc.
read at $250.09
Automatic Data Processing holds its Markup at $250.09.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | Elevated stress, defensive posture warranted, held for 1 days |
| Price | $250.09 |
| Valuation | 23.35 trailing · 20.49 forward price to earnings |
| Values screen | PASS · score 83.2 |
| Beta | 0.84 |
The opportunity · what the numbers say it is worth
Our framework reads OVERVALUED — it trades above our $238.34 fair value estimate, strong competitive moat, 7.00% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the Street see limited upside at this price.
| Revenue growth | 7.00% |
| Profit margin | 20.12% |
| Debt to equity | 69.26 |
| Analyst consensus | Hold · 15 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✓ PASSES
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is just 17.0% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 8.4% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 13.0% of assets, under the 49% limit. Pass
- Revenue purity Only 1.6% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Payroll leader priced past its fair value
Every firm must pay its people on time, and ADP runs the quiet systems that make that happen across millions of workers. The business stands out for a strong moat, 71 percent return on equity and 20 percent profit margins, yet the shares trade 9 percent above fair value on a 20.9 times forward multiple with revenue growth at just 7 percent.
Analyst consensus sits at hold with a median target below the current price, which matches our reading that the market has paid up for quality that is already well known. The ethical screen clears without issue, so the verdict rests on valuation alone.
High returns draw a premium, but stretching the multiple leaves little margin if growth eases or rates remain sticky. This is a solid operator at the wrong price. Analysis, not advice.
| Forward P/E | 20.5x expensive even after accounting for its growth |
| Trailing P/E | 23.4x a premium valuation |
| Revenue growth | 7.0% slow but positive growth |
| Profit margin | 20.1% healthy profit margins |
| Return on equity | 71.2% an exceptional return on shareholder capital |
| Debt to equity | 0.69 moderate, manageable leverage |
| Current ratio | 1.04 adequate liquidity, worth monitoring |
| Beta | 0.84 steadier than the market |
| Market cap | $100.0B |
| Employees | 67,000 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on ADP
- › Is Automatic Data Processing (ADP) A Better Stock Than PAYX and WDAY Insider Monkey · 9d ago
- › Intuit Reinvents Itself With AI: Should You Buy the Stock? Zacks · 11d ago
- › 2 Large-Cap Stocks on Our Buy List and 1 We Turn Down StockStory · 11d ago
- › INTU: Priced Like A Decline, Paying Like A Machine Trefis · 12d ago
- › 5 Quality Stocks With Recent Dividend Hikes to Watch Now Zacks · 12d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in ADP's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
ADP trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (15 analysts) rates it hold, with a mean price target of $246. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (15 analysts) rates it hold, with a mean price target of $246. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (15 analysts) rates it hold, with a mean price target of $246. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (15 analysts) rates it hold, with a mean price target of $246. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (15 analysts) rates it hold, with a mean price target of $246. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (15 analysts) rates it hold, with a mean price target of $246. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 10.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (15 analysts) rates it hold, with a mean price target of $246.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (15 analysts) rates it hold, with a mean price target of $246.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 25%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (15 analysts) rates it hold, with a mean price target of $246.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-08 | MICHAUD BRIAN L. | Officer | 848 | $179,886 | |
| 2026-05-07 | SWAN ROBERT HOLMES | Director | 3,619 | $745,695 | |
| 2026-04-14 | D'AMBROSIO CHRISTOPHER | Officer | 543 | $106,287 | |
| 2026-03-16 | D'AMBROSIO CHRISTOPHER | Officer | 543 | $113,188 | |
| 2026-02-17 | D'AMBROSIO CHRISTOPHER | Officer | 543 | $115,349 | |
| 2026-02-06 | MICHAUD BRIAN L. | Officer | 1,000 | $234,180 | |
| 2026-02-05 | FOSKETT DAVID | Officer | 266 | $63,042 | |
| 2026-01-13 | D'AMBROSIO CHRISTOPHER | Officer | 543 | $142,423 | |
| 2026-01-12 | KWON DAVID | Officer | 806 | $213,429 | |
| 2026-01-06 | KWON DAVID | Officer | 900 | $234,000 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-04-13 | Ro Khanna | Democrat | Purchase | 15K–50K |
| 16 Jun2026 | Gil Cisneros | Democrat | buy | 1K–15K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $211.67 | +8.9% | · | $1,089 | +8.9% |
| 2 months | $188.79 | +22.1% | · | $1,221 | +22.1% |
| 3 months | $205.75 | +12.1% | $1.70 | $1,129 | +12.9% |
| 6 months | $260.83 | -11.6% | $3.40 | $897 | -10.3% |
| 1 year | $306.80 | -24.9% | $6.48 | $773 | -22.7% |
| 2 years | $235.75 | -2.2% | $12.36 | $1,030 | +3.0% |
| 3 years | $202.10 | +14.1% | $16.41 | $1,222 | +22.2% |
| 5 years | $180.26 | +27.9% | $25.25 | $1,419 | +41.9% |
Historical returns from market close data. Past performance does not guarantee future results.